Life Sciences

True DX in the Pharma R&D Lab Defined by Enthought

May 25, 2022

Enthought’s team in Japan exhibited at the Pharma IT & Digital Health Expo 2022 life sciences conference in Tokyo, to meet with pharmaceutical industry leaders gathering for technological insight and to revitalize market growth. 200 companies exhibited across the 3-day in-person event, which drew over 6,700 attendees. With digital transformation a headline theme, the show…

Read More

Life Sciences Labs Optimize with New Digital Technologies and Upskilling

May 16, 2022

Labs are resetting the trajectory for drug development: reducing timelines from years to months; decreasing costs from billions to millions; and gaining an advantage by delivering drugs to market in months rather than decades. This value combination is a compelling case for investment in digital capability and organizational transformation. A 100x or 1000x advance in…

Read More

The Challenges of Scaling Digital Advances in Life Sciences

Oct 6, 2021

Scaling innovations in R&D can be considered challenging in two dimensions: from lab to lab; and from the lab to the end customer. A 100x or 1000x advance in R&D efficiency challenges an organization to adapt, from R&D to engineering, manufacturing, and to the marketplace, where there is a significant business opportunity. Author: Robyn Cardwell,…

Read More

Leveraging AI in Cell Culture Analysis

Jun 22, 2021

Mammalian cell culture is a fundamental tool for many discoveries, innovations and products in the life sciences. Currently, cells are the smallest unit of sustainable life outside the body, thereby providing an essential platform for testing hypotheses and mimicking biological processes. The applications of cell culture, while not limitless, are plentiful.  Every cell type, downstream…

Read More